NAD · dosing
NMN dosage: the studied range, and the number nobody has
NMN dosage in human trials has run from 250 mg to 1,200 mg daily for 4 to 12 weeks, per evidence aggregators. Those trials measured a blood marker, not a benefit, so no dose has been validated against an outcome.
What NMN doses have human trials used?
Early / mixed evidence Trials lasting 10 to 12 weeks used 250 mg to 900 mg daily, and the best NMN dosage evidence is a randomized, multicenter, double-blind, placebo-controlled dose-dependent trial in healthy middle-aged adults. It found that supplementation increased blood NAD concentrations and that oral dosing was safe and well tolerated up to 900 mg daily.[1]
The 250 mg trials
A separate Japanese trial gave 250 mg daily for twelve weeks to healthy adults, splitting it as 125 mg twice daily, and reported the same two things: safe, and blood NAD rose.[2]
Show the numbers as a table
| Measure | Value |
|---|---|
| Safety trial, 12 weeks | 250 mg/day |
| Women’s trial, 10 weeks | 250 mg/day |
| Dose-ranging top | 900 mg/day |
| Studied range top | 1,200 mg/day |
The trial that produced the strongest functional finding in this field, improved muscle insulin sensitivity in prediabetic postmenopausal women, used 250 mg daily for ten weeks.[3]
The studied range
Evidence aggregators place the studied range at 250 mg to 1,200 mg daily over four to twelve weeks, with brief use of higher amounts in research settings.[4]
Most studies are typically using about 500 milligrams per kilogram of NR, which is about 35 grams a day for a 70 kilogram human. Human studies are usually using about one gram.
Has any NMN dosage been validated?
No: a validated dose comes from testing several amounts against an outcome and finding where benefit and risk cross most favorably. That has not happened here, and the reason is structural: the endpoint that responds cleanly to dose is blood NAD, which is a marker rather than a result.
The awkwardness of that becomes clear in a trial of a closely related precursor, where supplementation successfully raised NAD in skeletal muscle and the functional and mitochondrial measures did not improve.[5] If raising the marker does not reliably move the outcome, then optimizing the dose against the marker optimizes nothing.
Where do the confident NMN dosage numbers come from?
The numbers on dosing charts trace back to three places, and none of them is a dose-finding study against an outcome.
- The studied range. Evidence aggregators report it accurately, and it is then repeated without its caveats.
- Manufacturer positioning. The phrase describing 900 mg as a gold standard appears in advertising rather than in a trial conclusion.
- Invention. This covers most of the dosing-by-age and dosing-by-weight tables in circulation.
Dosing by weight and by age
Those tables deserve particular skepticism. Human trials used fixed doses, not milligrams per kilogram, and no study has compared doses across age bands. A chart giving a 55-year-old a different number from a 35-year-old is extrapolating from a rationale, not reporting a result.
Does the timing or splitting of a dose matter?
Neither has been shown to matter in any trial: morning dosing is conventional and untested against evening dosing. Splitting a dose has been done in at least one safety trial and has never been compared with taking it all at once. Combining it with resveratrol, TMG or anything else is common practice with no comparative data behind it.
Conventions versus measurements
None of that means the practices are wrong. It means they are conventions, and it is worth knowing which parts of a protocol are measurements and which are habits. The same distinction runs through our page on what the human trials found.
Are doses up to 900 mg safe?
For the weeks tested, yes: trials up to 900 mg found no serious adverse events, and the effects reported at any dose are mild and uncommon. That covers weeks to a few months in modest numbers of participants.
Show the numbers as a table
| When | Event | Detail |
|---|---|---|
| 2021 | Women’s trial | 250 mg for 10 weeks |
| 2022 | Safety trial | 250 mg for 12 weeks |
| 2023 | Dose-ranging trial | Tolerated to 900 mg |
| Sep 2025 | FDA reversal | Lawful as supplement |
What the short trials cannot show
It does not cover years, which is how people actually take it. NAD metabolism intersects with cell growth and repair pathways, so indefinite supplementation in healthy people is a genuinely open question rather than a resolved one. Our page on the side effect picture goes through what has been reported.
How should a dose be chosen?
With a clinician, from inside the studied range. People asking how much nmn to take usually want a single number. The honest answer is a range with a caveat attached, and the choice of dose belongs in a conversation with a clinician who knows your medications.
Staying inside the studied range
The studied range is the only territory with evidence around it. Its low end is where a real trial found tolerability over twelve weeks, and any higher figure buys more of a marker rather than more of a benefit.[2]
I don't think that people really have to go higher than a gram.
Give it eight to twelve weeks before deciding anything, since that is how long the trials that found effects took to find them. And note that the regulatory footing under the whole category has shifted more than once, which is a reason to prefer third-party tested products.[6] Our reviews of NMN products and the wider NAD category cover that.
The one thing worth resisting is the confidence of the dosing charts. NAD decline with age is real.[7] The precise milligram figure that corrects it usefully is not something anyone currently knows.
Frequently asked questions
What is the right NMN dosage?
No dose has been validated against a functional benefit, so there is no right answer in the sense the question implies. Trials have used 250 mg to 1,200 mg daily, and the dose-ranging study found blood NAD rising with dose and tolerability holding up to 900 mg.
Did any trial compare NMN doses against a health outcome?
No. The dose-ranging trial compared doses against blood NAD and tolerability rather than a functional outcome, and the one trial with a functional gain tested a single 250 mg dose for ten weeks.
Is 500 mg of NMN enough?
Enough for what is the missing half of the question. It sits inside the studied range and will raise blood NAD. Whether any dose produces a benefit you would notice is the open question the whole category rests on.
Should NMN dosage be based on body weight?
There is no weight-based dosing evidence in humans. Trials used fixed doses, not milligrams per kilogram, so weight-based charts in circulation are extrapolated rather than measured.
Does NMN dosage change with age?
Not on any published evidence. Age-adjusted dosing tables exist online but no trial has compared doses across age groups against an outcome. The rationale offered, that older people have lower NAD, is a reason to study it rather than a finding.
Is blood NAD a reliable way to judge a dose?
Only as a marker. It rises with dose, but a trial of a related precursor raised muscle NAD without improving muscle function, so a higher reading is not evidence that a dose is doing anything useful.
Should the dose be split?
One safety trial used 125 mg twice daily rather than 250 mg once. Splitting is reasonable and untested comparatively. Nobody has shown that steadier blood levels produce a better result, because nobody has shown which blood level to aim for.
Is 1,000 mg of NMN safe?
The dose-ranging trial reported oral dosing safe and well tolerated up to 900 mg daily, and other studies have used up to 1,200 mg for several weeks. Those are short-duration findings in modest numbers of people, not a long-term safety statement.
How long until NMN works?
Blood NAD rises within one to two weeks. In the trials that found any functional change, it took eight to twelve weeks. If nothing has happened after three months at a studied dose, more months are unlikely to change that.
Is there a maximum safe dose?
No upper limit has been established. Doses of 2,000 mg have been used briefly in research. The absence of a defined ceiling reflects a shortage of long-term studies rather than a demonstration of safety at any amount.
Does more NMN raise NAD more?
Yes, dose-dependently, which is exactly what the dose-ranging trial found. The problem is that blood NAD is a biomarker, not an outcome, and raising it further has not been shown to deliver anything further.
Can I take NMN with other supplements?
It is commonly stacked with resveratrol, TMG or a multivitamin, and none of those combinations has been tested against the compound alone. Stacking multiplies cost and untested variables at the same rate.
Should I cycle NMN?
No cycling protocol has been studied. The schedules circulating online are reasoning by analogy from other compounds rather than results from anything measured with this one.
What dose should I actually choose?
That is a decision to make with a clinician who knows your medications and history rather than from a webpage. What this page can say is that the studied range is 250 mg to 1,200 mg daily and that no dose within it has been shown to produce a benefit you would notice.
References
7 sources, all link-checked; oldest check
- The efficacy and safety of beta-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Yi L et al. GeroScience 2023 (cited 260).Dose-ranging trial; blood NAD rose with dose and oral dosing up to 900 mg daily was safe and well tolerated.Verified Sep 15, 2026
- Oral administration of nicotinamide mononucleotide is safe and efficiently increases blood nicotinamide adenine dinucleotide levels in healthy subjects. Okabe K et al. Frontiers in Nutrition 2022 (cited 134).250 mg daily for 12 weeks in healthy adults was safe and well tolerated and raised blood NAD.Verified Sep 15, 2026
- Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Yoshino M et al. Science 2021;372(6547):1224–1229.Publisher blocks automated checks · last tried Sep 15, 2026
- Nicotinamide mononucleotide (NMN): evidence summary. Examine.com.Publisher blocks automated checks · last tried Sep 15, 2026
- Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Elhassan YS et al. Cell Reports 2019;28(7):1717–1728.e6.Raised muscle NAD+ metabolites without a matching change in functional performance.Verified Sep 15, 2026
- NAD+ supplements: can they really slow down aging?. Cleveland Clinic Health Essentials, 26 February 2026.Mainstream clinical overview; notes NAD+ itself is a large molecule and that most products supply precursors instead.Verified Sep 15, 2026
- FDA response to citizen petition on beta-nicotinamide mononucleotide (NMN). US Food and Drug Administration, letter of 29 September 2025, docket FDA-2023-P-0872.Reversal of the 2022 position: FDA concluded NMN is not drug-precluded and is not excluded from the dietary supplement definition.Verified Sep 15, 2026
Every link above is re-requested on a schedule by an automated checker; the date shown is when it last answered. Publishers that block automated requests are marked as such rather than reported broken. Our editorial standards explain how a source gets cited here in the first place.
Filed by the Rapamycin.store evidence desk. Each source is re-checked when the page is reviewed.
Own a longevity or health brand?
Rapamycin.store publishes sponsored and guest posts on an aged, topically-relevant domain, and offers display advertising. Tell us what you want to promote and we'll send our current options.